Pricing Log in Create free account

Nuvectis Pharma, Inc. (NVCT) vs Olema Pharmaceuticals, Inc. (OLMA)

Nuvectis Pharma, Inc. and Olema Pharmaceuticals, Inc. are both Biotechnology companies. Nuvectis Pharma, Inc. and Olema Pharmaceuticals, Inc. are of similar size ($591.5M and $579.8M). Across the 9 metrics below, Nuvectis Pharma, Inc. leads on 5 and Olema Pharmaceuticals, Inc. on 4.

Valuation

Metric NVCT OLMA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 4.84 1.77 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (9.08%) (29.04%) (32.88%)
Free cash flow yield (6.57%) (21.63%) (23.13%)

Profitability

Metric NVCT OLMA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (66.98%) (52.74%) (51.96%)
Return on assets (57.20%) (47.10%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NVCT OLMA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (18.92%) 15.00% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NVCT OLMA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 9.92 8.86 4.97
Net debt to EBITDA 1.15 2.82 1.01

Dividend

Metric NVCT OLMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NVCT OLMA Biotechnology median
Market cap 579.76m 591.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack